METHOD FOR TREATMENT OF CHRONIC VIRAL HEPATITIS C OF GENOTYPE-2 WITH MODERATE ACTIVITY

FIELD: medicine, hepatology, virology. ^ SUBSTANCE: invention relates to a method for treatment of chronic viral hepatitis C of genotype-2 with moderate activity. Method is carried out by every day parenteral administration of solutions containing a mixture of amino acids, nucleosides and enzyme. In...

Full description

Saved in:
Bibliographic Details
Main Authors RADCHENKO VALERIJ GRIGOR'EVICH, CHALISOVA NATAL'JA IOSIFOVNA, KHAAZE GJUNTER, KOMASHNJA ARTEM VLADIMIROVICH
Format Patent
LanguageEnglish
Russian
Published 20.02.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:FIELD: medicine, hepatology, virology. ^ SUBSTANCE: invention relates to a method for treatment of chronic viral hepatitis C of genotype-2 with moderate activity. Method is carried out by every day parenteral administration of solutions containing a mixture of amino acids, nucleosides and enzyme. In the first day 0.2 ml of 0.01% solution of a solution containing a mixture of amino acids: lysine, arginine, asparagines, glutamic acid taken in the equal amounts is administrated; in the next day 0.2 ml of 0.02% solution containing a mixture of nucleosides: adenosine, inosine, amino acids, guanosine, and enzyme lysozyme also taken in equal amounts. Administration of solution is alternated every day during carrying out the treatment course and each 2 months break in administration of amino acids is carried out for 28-32 days. After 9-11 days of administration of proposed solutions method involves additional course of parenteral administration of interferon-alpha 2b in the dose 3 ml IU, 3 times per a week for 6 months. The total duration of treatment course is 6 months, 9 days - 6 months, 11 days. Method provides clinical remission and elimination of hepatitis virus and normalization of biochemical indices for 6 months after termination of treatment. ^ EFFECT: improved method of treatment. ^ 2 tbl, 4 ex
Bibliography:Application Number: RU20050122761